These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 12009896
1. Identification of human vesicle monoamine transporter (VMAT2) lumenal cysteines that form an intramolecular disulfide bond. Thiriot DS, Sievert MK, Ruoho AE. Biochemistry; 2002 May 21; 41(20):6346-53. PubMed ID: 12009896 [Abstract] [Full Text] [Related]
2. Mutagenesis and derivatization of human vesicle monoamine transporter 2 (VMAT2) cysteines identifies transporter domains involved in tetrabenazine binding and substrate transport. Thiriot DS, Ruoho AE. J Biol Chem; 2001 Jul 20; 276(29):27304-15. PubMed ID: 11375404 [Abstract] [Full Text] [Related]
3. A leucine-based motif mediates the endocytosis of vesicular monoamine and acetylcholine transporters. Tan PK, Waites C, Liu Y, Krantz DE, Edwards RH. J Biol Chem; 1998 Jul 10; 273(28):17351-60. PubMed ID: 9651318 [Abstract] [Full Text] [Related]
4. Identification of residues involved in substrate recognition by a vesicular monoamine transporter. Merickel A, Rosandich P, Peter D, Edwards RH. J Biol Chem; 1995 Oct 27; 270(43):25798-804. PubMed ID: 7592763 [Abstract] [Full Text] [Related]
5. An acidic motif retains vesicular monoamine transporter 2 on large dense core vesicles. Waites CL, Mehta A, Tan PK, Thomas G, Edwards RH, Krantz DE. J Cell Biol; 2001 Mar 19; 152(6):1159-68. PubMed ID: 11257117 [Abstract] [Full Text] [Related]
6. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine. Peter D, Vu T, Edwards RH. J Biol Chem; 1996 Feb 09; 271(6):2979-86. PubMed ID: 8621690 [Abstract] [Full Text] [Related]
7. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E. Proc Natl Acad Sci U S A; 1996 May 14; 93(10):5166-71. PubMed ID: 8643547 [Abstract] [Full Text] [Related]
8. Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2. Finn JP, Edwards RH. J Biol Chem; 1997 Jun 27; 272(26):16301-7. PubMed ID: 9195934 [Abstract] [Full Text] [Related]
11. Phosphorylation of a vesicular monoamine transporter by casein kinase II. Krantz DE, Peter D, Liu Y, Edwards RH. J Biol Chem; 1997 Mar 07; 272(10):6752-9. PubMed ID: 9045708 [Abstract] [Full Text] [Related]
12. Transport of histamine by vesicular monoamine transporter-2. Merickel A, Edwards RH. Neuropharmacology; 1995 Nov 07; 34(11):1543-7. PubMed ID: 8606801 [Abstract] [Full Text] [Related]
19. Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles. Varoqui H, Erickson JD. J Physiol Paris; 1998 Apr 07; 92(2):141-4. PubMed ID: 9782458 [Abstract] [Full Text] [Related]